Cardiac Anesthesia Registry Including Biosignal Database for Prognostication of Postoperative Renal Outcome

August 29, 2024 updated by: Yonsei University

Cardiac Anesthesia Registry Including Biosignal Database for Prognostication of Postoperative Renal Outcome: Cardiac Anesthesia Renal Outcome in Severance Cardiovascular Hospital - DataBase (CARS-DB)

AKI(Acute Kidney Injury) is a common complication after cardiac surgery which is associated with increased mortality and morbidity. Collecting perioperative biosignal data and studying their association with renal outcomes can help improve kidney injury, mortality, and morbidity in cardiac surgical patients. Furthermore, the occurrence of AKI, length of hospital stay, and recovery of renal function after discharge are closely associated with the development of chronic kidney disease (CKD). Therefore, regular monitoring of renal function and related indicators in cardiac surgical patients can help improve long-term outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients aged 19 year and older admitted to Severance cardiovascular hospital for cardiac surgery using CPB (Cardiopulmonary bypass).

Description

Inclusion Criteria:

  • Aged 19 years and older scheduled for cardiac surgery using CPB

Exclusion Criteria:

  • emergency operation, the patient is foreigner or illiterate and unable to read the consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
anesthesia for cardiovascular surgery using cardiopulmonary bypass
patients scheduled for cardiovascular surgery with CPB which requires anesthesia in the operating room

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post-operative AKI incidence within 1 week after cardiac surgery with CPB
Time Frame: within first 7 days after surgery
The definition of AKI refers to Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury.
within first 7 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MAKE 30 (Major adverse kidney event within 30 days)
Time Frame: within 30 days after surgery
death, starting dialysis, or decrease in eGFR of 25 % or more within 30 days after surgery
within 30 days after surgery
MAKE 90 (Major Adverse kidney event within 90 days)
Time Frame: within 90 days after surgery
death, starting dialysis, or decrease in eGFR of 25 % or more within 90 days after surgery
within 90 days after surgery
incidence of CKD (chronic kidney disease) within 1 year
Time Frame: within 1 year after surgery

at least one of the following criteria is met, with structural or functional abnormalities of the kidney persisting for at least 3 months within 1 year

  • urine albumin/creatinine ratio ≥ 30 mg/g
  • abnormality in urine sediment test or persistent hematuria
  • renal structural abnormalities found in image study
  • eGFR < 60 ml/min/1.73m2 (GFR category G3a-G5)
within 1 year after surgery
1 year mortality
Time Frame: within 1 year after surgery
death due to any cause within 1 year
within 1 year after surgery
in-hospital mortality
Time Frame: from day of hospitalization for surgery until discharge after surgery 1year
death which occurs during the hospitalization
from day of hospitalization for surgery until discharge after surgery 1year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

August 1, 2034

Study Completion (Estimated)

September 30, 2034

Study Registration Dates

First Submitted

June 27, 2024

First Submitted That Met QC Criteria

August 29, 2024

First Posted (Actual)

September 3, 2024

Study Record Updates

Last Update Posted (Actual)

September 3, 2024

Last Update Submitted That Met QC Criteria

August 29, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Anaesthesia

Subscribe